Abstract
Antibiotic resistance is a critical global health concern, leading to the reduced efficacy of existing antibiotics and posing challenges in the treatment of bacterial infections. As resistance to antibiotics continues to rise, new pharmacological approaches are required to address this pressing issue. This article explores the various strategies employed in the development of novel pharmacological agents to combat antibiotic resistance. These approaches include the discovery of new antibiotics, the development of resistance-modifying agents, and the use of combination therapies. Additionally, the article discusses alternative strategies such as phage therapy, immune modulation, and enzyme inhibitors. The pharmacological innovations discussed aim to not only restore the effectiveness of existing antibiotics but also provide new avenues for treating resistant infections. The article concludes by highlighting the importance of interdisciplinary collaboration in addressing antibiotic resistance.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.